FTH

Faeth Therapeutics, Inc. - Common Stock (FTH)

About Faeth Therapeutics, Inc. - Common Stock (FTH)

Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.

Details

Daily high
$35.30
Daily low
$32.39
Price at open
$32.39
52 Week High
$37.90
52 Week Low
$7.21
Market cap
846.8M
Dividend yield
-
Volume
335,931
Avg. volume
304,519
P/E ratio
-.23

Faeth Therapeutics, Inc. - Common Stock News

Details

Daily high
$35.30
Daily low
$32.39
Price at open
$32.39
52 Week High
$37.90
52 Week Low
$7.21
Market cap
846.8M
Dividend yield
-
Volume
335,931
Avg. volume
304,519
P/E ratio
-.23